Matches in SemOpenAlex for { <https://semopenalex.org/work/W2740076773> ?p ?o ?g. }
- W2740076773 endingPage "2796" @default.
- W2740076773 startingPage "2796" @default.
- W2740076773 abstract "Abstract Homologous recombination (HR) repair deficiency confers sensitivity to inhibitors of poly(ADP-ribose) polymerase (PARP). To date, the identification of tumors with impaired HR has relied on genomic features, including mutational signature, LOH-based HRD assays or gene expression analyses defining ‘BRCAness’. These tests analyze history of the tumor rather than providing a functional assessment of HR status at the time of diagnosis. Therefore, development of a functional assay for HR status in tumors is essential to make accurate treatment decisions. Here, we describe a RAD51-based immunohistochemical (IHC) assay that identifies HR status. We first screened commercial anti-RAD51 antibodies and identified a monoclonal antibody that detects RAD51 foci in HR-competent normal fibroblasts and shows no evidence of foci in HR-deficient (BRCA2-/-) VU423 fibroblasts after γ-irradiation. Conditions for detecting RAD51 foci in FFPE samples were identified using HR-deficient and HR-proficient triple-negative breast cancer cell lines. HR-deficient, PARP inhibitor-sensitive cell lines exhibited high levels of nuclear RAD51 and no evidence of foci, whereas HR-proficient, PARP inhibitor-resistant cells had low levels of nuclear RAD51 and foci. This result was confirmed in a BRCA1-mutated, PARP inhibitor-sensitive PDX model, where there was no evidence of foci although RAD51 levels were high. We further evaluated the pattern of RAD51 staining in 13 high-grade serous ovarian cancer (HGSOC) PDX models, for which sensitivity to olaparib had been characterized. The only olaparib-sensitive model demonstrated complete absence of RAD51 staining. Among the other 12 olaparib-resistant models, RAD51 foci were detectable, both before and after irradiation. The presence or absence of RAD51 foci correlated with olaparib sensitivity and not with BRCA mutation status. Therefore, tumors that are HR-deficient and PARP inhibitor-sensitive are characterized by either high RAD51 nuclear staining without foci, or absence of RAD51 staining. To validate these findings, we analyzed RAD51 staining patterns in a cohort of 50 primary HGSOCs from patients subsequently treated with platinum-based chemotherapy. Among these 50 samples, 45 demonstrated either RAD51 nuclear staining without foci or an absence of RAD51 staining. Five samples demonstrated RAD51 staining with foci. The median survivals of these groups were 6.1 and 1.5 years, respectively. In conclusion, we have developed a robust IHC assay for determining the functional HR-status in tumor samples. Further work will be required to determine if the staining patterns observed predict PARP inhibitor sensitivity among primary patient samples. Funded by a Biomarker Supplement to UM1 CA186709, NIH Grant P50 CA168504, SU2C Ovarian Cancer Dream Team and BCRF grant. Citation Format: Bose S. Kochupurakkal, Kalindi Parmar, Jean-Bernard Lazaro, Christine Unitt, Qing Zeng, Hunter Reavis, Chirag Ganesa, Shan Zhou, Joyce Liu, Sangeetha Palakurthi, Kyle Strickland, Brooke Howitt, Panagiotis Konstantinopoulos, Paul Kirschmeier, Joseph Geradts, Ronny Drapkin, Ursula Matulonis, Alan D'Andrea, Geoffrey Shapiro. Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 2796. doi:10.1158/1538-7445.AM2017-2796" @default.
- W2740076773 created "2017-08-08" @default.
- W2740076773 creator A5002353139 @default.
- W2740076773 creator A5002974865 @default.
- W2740076773 creator A5015273969 @default.
- W2740076773 creator A5023615912 @default.
- W2740076773 creator A5034758372 @default.
- W2740076773 creator A5043442872 @default.
- W2740076773 creator A5044648110 @default.
- W2740076773 creator A5045419282 @default.
- W2740076773 creator A5048072263 @default.
- W2740076773 creator A5054283476 @default.
- W2740076773 creator A5058249824 @default.
- W2740076773 creator A5060953135 @default.
- W2740076773 creator A5061857391 @default.
- W2740076773 creator A5065593057 @default.
- W2740076773 creator A5073858657 @default.
- W2740076773 creator A5076246054 @default.
- W2740076773 creator A5077702152 @default.
- W2740076773 creator A5078345390 @default.
- W2740076773 creator A5088192892 @default.
- W2740076773 date "2017-07-01" @default.
- W2740076773 modified "2023-09-27" @default.
- W2740076773 title "Abstract 2796: Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity" @default.
- W2740076773 doi "https://doi.org/10.1158/1538-7445.am2017-2796" @default.
- W2740076773 hasPublicationYear "2017" @default.
- W2740076773 type Work @default.
- W2740076773 sameAs 2740076773 @default.
- W2740076773 citedByCount "3" @default.
- W2740076773 countsByYear W27400767732020 @default.
- W2740076773 countsByYear W27400767732021 @default.
- W2740076773 countsByYear W27400767732022 @default.
- W2740076773 crossrefType "journal-article" @default.
- W2740076773 hasAuthorship W2740076773A5002353139 @default.
- W2740076773 hasAuthorship W2740076773A5002974865 @default.
- W2740076773 hasAuthorship W2740076773A5015273969 @default.
- W2740076773 hasAuthorship W2740076773A5023615912 @default.
- W2740076773 hasAuthorship W2740076773A5034758372 @default.
- W2740076773 hasAuthorship W2740076773A5043442872 @default.
- W2740076773 hasAuthorship W2740076773A5044648110 @default.
- W2740076773 hasAuthorship W2740076773A5045419282 @default.
- W2740076773 hasAuthorship W2740076773A5048072263 @default.
- W2740076773 hasAuthorship W2740076773A5054283476 @default.
- W2740076773 hasAuthorship W2740076773A5058249824 @default.
- W2740076773 hasAuthorship W2740076773A5060953135 @default.
- W2740076773 hasAuthorship W2740076773A5061857391 @default.
- W2740076773 hasAuthorship W2740076773A5065593057 @default.
- W2740076773 hasAuthorship W2740076773A5073858657 @default.
- W2740076773 hasAuthorship W2740076773A5076246054 @default.
- W2740076773 hasAuthorship W2740076773A5077702152 @default.
- W2740076773 hasAuthorship W2740076773A5078345390 @default.
- W2740076773 hasAuthorship W2740076773A5088192892 @default.
- W2740076773 hasConcept C102744134 @default.
- W2740076773 hasConcept C104317684 @default.
- W2740076773 hasConcept C134935766 @default.
- W2740076773 hasConcept C153911025 @default.
- W2740076773 hasConcept C182979987 @default.
- W2740076773 hasConcept C203014093 @default.
- W2740076773 hasConcept C204232928 @default.
- W2740076773 hasConcept C2778502085 @default.
- W2740076773 hasConcept C2779012473 @default.
- W2740076773 hasConcept C2779138821 @default.
- W2740076773 hasConcept C2779962180 @default.
- W2740076773 hasConcept C502942594 @default.
- W2740076773 hasConcept C54355233 @default.
- W2740076773 hasConcept C82381507 @default.
- W2740076773 hasConcept C86803240 @default.
- W2740076773 hasConceptScore W2740076773C102744134 @default.
- W2740076773 hasConceptScore W2740076773C104317684 @default.
- W2740076773 hasConceptScore W2740076773C134935766 @default.
- W2740076773 hasConceptScore W2740076773C153911025 @default.
- W2740076773 hasConceptScore W2740076773C182979987 @default.
- W2740076773 hasConceptScore W2740076773C203014093 @default.
- W2740076773 hasConceptScore W2740076773C204232928 @default.
- W2740076773 hasConceptScore W2740076773C2778502085 @default.
- W2740076773 hasConceptScore W2740076773C2779012473 @default.
- W2740076773 hasConceptScore W2740076773C2779138821 @default.
- W2740076773 hasConceptScore W2740076773C2779962180 @default.
- W2740076773 hasConceptScore W2740076773C502942594 @default.
- W2740076773 hasConceptScore W2740076773C54355233 @default.
- W2740076773 hasConceptScore W2740076773C82381507 @default.
- W2740076773 hasConceptScore W2740076773C86803240 @default.
- W2740076773 hasIssue "13_Supplement" @default.
- W2740076773 hasLocation W27400767731 @default.
- W2740076773 hasOpenAccess W2740076773 @default.
- W2740076773 hasPrimaryLocation W27400767731 @default.
- W2740076773 hasRelatedWork W2162110229 @default.
- W2740076773 hasRelatedWork W2275017960 @default.
- W2740076773 hasRelatedWork W2480947811 @default.
- W2740076773 hasRelatedWork W2524304261 @default.
- W2740076773 hasRelatedWork W2899017452 @default.
- W2740076773 hasRelatedWork W3133711274 @default.
- W2740076773 hasRelatedWork W3172380618 @default.
- W2740076773 hasRelatedWork W3187637740 @default.
- W2740076773 hasRelatedWork W4250426713 @default.
- W2740076773 hasRelatedWork W4320498889 @default.
- W2740076773 hasVolume "77" @default.
- W2740076773 isParatext "false" @default.